![Karen Vousden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 796 773 $ al 31/10/2026
Dr. Karen H.
Vousden is an Independent Director at Bristol Myers Squibb Co., an Associate at National Academy of Sciences, a Council Member at European Molecular Biology Organization and a President at British Association for Cancer Research.
She is on the Board of Directors at Faeth Therapeutics, Inc. and Bristol Myers Squibb Co. Dr. Vousden was previously employed as a Co-Founder by Faeth Therapeutics LLC.
She also served on the board at The Beatson Institute For Cancer Research.
She received her doctorate degree from Queen Mary University of London.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
FAETH THERAPEUTICS, INC. 0,17 % | 11/09/2026 | 42.631 ( 0,17 % ) | 796 773 $ | 31/10/2026 |
| 12/03/2026 | 0 ( -.--% ) | - $ | 31/10/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Director/Miembro de la Junta | 01/01/2018 |
| FAETH THERAPEUTICS, INC. | Director/Miembro de la Junta | 11/09/2026 |
British Association for Cancer Research
 British Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as a charity for cancer research | Presidente | - |
European Molecular Biology Organization | Corporate Officer/Principal | - |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
The Beatson Institute For Cancer Research
 The Beatson Institute For Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as cancer research institute | Director/Miembro de la Junta | 01/01/2016 |
Faeth Therapeutics, Inc.
 Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision nutrition cancer treatment solutions which uses metabolism to starve cancer cells | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
European Molecular Biology Organization | |
British Association for Cancer Research
British Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as a charity for cancer research | Commercial Services |
The Beatson Institute For Cancer Research
The Beatson Institute For Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as cancer research institute | Commercial Services |
Queen Mary University of London
 Queen Mary University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision nutrition cancer treatment solutions which uses metabolism to starve cancer cells | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
